Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Oric Pharmaceuticals (ORIC) Other Non Operating Income (2019 - 2021)

Oric Pharmaceuticals filings provide 3 years of Other Non Operating Income readings, the most recent being $15000.0 for Q2 2021.

  • Quarterly Other Non Operating Income fell 79.73% to $15000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $8000.0 through Dec 2021, down 95.48% year-over-year, with the annual reading at $15000.0 for FY2021, 91.53% down from the prior year.
  • Other Non Operating Income hit $15000.0 in Q2 2021 for Oric Pharmaceuticals, up from -$7000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $74000.0 in Q4 2019 and bottomed at -$7000.0 in Q4 2020.
  • Average Other Non Operating Income over 3 years is $53444.4, with a median of $70000.0 recorded in 2019.
  • Peak annual rise in Other Non Operating Income hit 1.37% in 2020, while the deepest fall reached 109.46% in 2020.
  • Oric Pharmaceuticals' Other Non Operating Income stood at $74000.0 in 2019, then crashed by 109.46% to -$7000.0 in 2020, then surged by 314.29% to $15000.0 in 2021.
  • Per Business Quant, the three most recent readings for ORIC's Other Non Operating Income are $15000.0 (Q2 2021), -$7000.0 (Q4 2020), and $44000.0 (Q3 2020).